Kinetic studies of fluorocurcumin derivatives with anticancer activity
Two novel fluorocurcumin adducts with a difluoroboryl group exhibited activity in vitro against two bladder cancer cell lines, namely 5637 and SCaBER. The stability was evaluated under physiologically relevant conditions to mimic both the digestive tract and the bladder environment. Therefore, exper...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Book |
Published: |
Polskie Towarzystwo Farmaceutyczne,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_8c54d879933240c5ba5107d1010e5ffc | ||
042 | |a dc | ||
100 | 1 | 0 | |a Joanna Kuźmińska |e author |
700 | 1 | 0 | |a Agnieszka Sobczak |e author |
700 | 1 | 0 | |a Izabela Muszalska-Kolos |e author |
700 | 1 | 0 | |a Anna Jelińska |e author |
700 | 1 | 0 | |a Weronika Jankowska |e author |
700 | 1 | 0 | |a Tomasz Goslinski |e author |
245 | 0 | 0 | |a Kinetic studies of fluorocurcumin derivatives with anticancer activity |
260 | |b Polskie Towarzystwo Farmaceutyczne, |c 2023-06-01T00:00:00Z. | ||
500 | |a 0001-6837 | ||
500 | |a 10.32383/appdr/163486 | ||
520 | |a Two novel fluorocurcumin adducts with a difluoroboryl group exhibited activity in vitro against two bladder cancer cell lines, namely 5637 and SCaBER. The stability was evaluated under physiologically relevant conditions to mimic both the digestive tract and the bladder environment. Therefore, experiments were performed in hydrochloric acid at pH 1.2, and in buffer solutions with pH from 4.5 to 6.8 at 37°C. A validated HPLC method, allowing the monitoring of changes in substrates and products concentrations over time, was applied. Notably, the main decomposition product was the fluorocurcumin derivative without the difluoroboryl group. The decomposition of the fluorocurcumin adducts to the major products undergoes the pseudo-first-order kinetics reaction. | ||
546 | |a EN | ||
690 | |a hplc | ||
690 | |a degradation | ||
690 | |a validation | ||
690 | |a kinetic studies | ||
690 | |a fluorocurcumin derivative | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Acta Poloniae Pharmaceutica, Vol 80, Iss 2, Pp 235-244 (2023) | |
787 | 0 | |n https://www.ptfarm.pl/download/?file=File%2FActa_Poloniae%2F2023%2F2%2F235.pdf | |
787 | 0 | |n https://doaj.org/toc/0001-6837 | |
856 | 4 | 1 | |u https://doaj.org/article/8c54d879933240c5ba5107d1010e5ffc |z Connect to this object online. |